If you weren’t there Misha don’t comment . I was and there and they explained fully what the issues were with the first submittion . The reply to the COC was only submitted last night so how could they have gotten a reply by now ? . As for your comment about using data from older Chemo treatments the current application shows the results of virtually every Chemo drug that has ever been trialed on Pancreatic cancer and yes Oncosil devise show a real advantage compared to all these treatments . That was the problem with the first submittion , Oncosil only showed the comparisons of the Chemo drugs used in the PanCo trial if used by themselves in the original submittion .
Ann: OncoSil AGM CEO Presentation, page-11
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(3.57%) |
Mkt cap ! $51.08M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.3¢ | $10.95K | 818.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 6877744 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 6707716 | 19 |
View Market Depth
| Last trade - 14.41pm 18/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |